Skip to main content

Plasminogen Activator Inhibitor (PAI-1)

  • Reference work entry
  • 56 Accesses

Definition

The rupture of an atherosclerotic plaque is a recognized key event in acute ischemic syndromes, such as myocardial infarctions. The intravascular thrombotic response to a ruptured plaque is a complex cascade of thrombogenic (clot-forming) and thrombolytic (clot-dissolving) mechanisms. A key component of the thrombotic cascade is plasminogen activator inhibitor type 1 (PAI-1). PAI-1 inhibits the activation of plasminogen by tissue plasminogen activator (tPA) and urokinase (uPA) and, hence, inhibits clot lysis.

PAI-1 is a single-chain glycoprotein composed of nearly 380 amino acids. It is a member of the serine proteases family and is synthesized by vascular endothelium and smooth muscle cells in both normal and atherosclerotic arteries. By synthesizing molecules like PAI-1, arterial smooth muscle cells can prevent bleeding from small vascular injuries; congenital deficiencies of PAI-1 are a rare cause of abnormal bleeding.

Associations between PAI-1 and incident or recurrent...

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   1,199.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References and Readings

  • Humphries, S. E., Panahloo, A., Montgomery, H. E., Green, F., & Yudkin, J. (1997). Gene-environment interaction in the determination of levels of haemostatic variables involved in thrombosis and fibrinolysis. Thrombosis and Haemostasis, 78(1), 457–461.

    PubMed  CAS  Google Scholar 

  • Juhan-Vague, I., Pyke, S. D., Alessi, M. C., Jespersen, J., Haverkate, F., & Thompson, S. G. (1996). Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation, 94(9), 2057–2063.

    Article  PubMed  CAS  Google Scholar 

  • Lee, M. H., Vosburgh, E., Anderson, K., & McDonagh, J. (1993). Deficiency of plasma plasminogen activator inhibitor 1 results in hyperfibrinolytic bleeding. Blood, 81(9), 2357–2362.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonathan Newman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media, New York

About this entry

Cite this entry

Newman, J. (2013). Plasminogen Activator Inhibitor (PAI-1). In: Gellman, M.D., Turner, J.R. (eds) Encyclopedia of Behavioral Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1005-9_1279

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-1005-9_1279

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4419-1004-2

  • Online ISBN: 978-1-4419-1005-9

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics